{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:24:44Z","timestamp":1761852284480,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the National Medical Association"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jnma.2017.07.003","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T02:01:23Z","timestamp":1500948083000},"page":"343-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk Factors Influencing Outcomes of Atrial Fibrillation in ALLHAT"],"prefix":"10.1016","volume":"110","author":[{"given":"L. Julian","family":"Haywood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda B.","family":"Piller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara M.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alokananda","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula T.","family":"Einhorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles E.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey L.","family":"Probstfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsayed Z.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Jackson T.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jnma.2017.07.003_bib1","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics \u2013 2017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jnma.2017.07.003_bib2","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCULATIONAHA.110.009035","article-title":"Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the atherosclerosis risk in communities (ARIC) study","volume":"123","author":"Huxley","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jnma.2017.07.003_bib3","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.jacc.2009.08.020","article-title":"Atrial fibrillation at baseline and during follow-up in ALLHAT (antihypertensive and lipid-lowering treatment to prevent heart attack trial)","volume":"54","author":"Haywood","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jnma.2017.07.003_bib4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jnma.2017.07.003_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jacc.2003.09.035","article-title":"Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the epidemiology, practice, outcomes, and costs of heart failure (EPOCH) study","volume":"43","author":"Ruo","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jnma.2017.07.003_bib6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/eurheartj\/ehi694","article-title":"Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades","volume":"27","author":"Miyasaka","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jnma.2017.07.003_bib7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/01.HYP.0000052830.02773.E4","article-title":"Atrial fibrillation in hypertension: predictors and outcome","volume":"41","author":"Verdecchia","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jnma.2017.07.003_bib8","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1212\/WNL.0000000000003321","article-title":"Increasing atrial fibrillation prevalence in acute ischemic stroke and TIA","volume":"87","author":"Otite","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jnma.2017.07.003_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/jamainternmed.2013.11912","article-title":"Atrial fibrillation and the risk of myocardial infarction","volume":"174","author":"Soliman","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jnma.2017.07.003_bib10","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/clc.22339","article-title":"Atrial fibrillation and incident myocardial infarction in the elderly","volume":"37","author":"O'Neal","year":"2014","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jnma.2017.07.003_bib11","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/CIRCULATIONAHA.112.000491","article-title":"Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study","volume":"128","author":"Marijon","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jnma.2017.07.003_bib12","article-title":"Influence of prevalent and incident atrial fibrillation on post-trial major events in ALLHAT","author":"Haywood","year":"2017","journal-title":"J\u00a0Natl Med Assoc"},{"key":"10.1016\/j.jnma.2017.07.003_bib13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0895-7061(96)00037-4","article-title":"Rationale and design for the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"9","author":"Davis","year":"1996","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jnma.2017.07.003_bib14","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1001\/jama.288.23.2998","article-title":"Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT-LLT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jnma.2017.07.003_bib15","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jnma.2017.07.003_bib16","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","article-title":"Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"283","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jnma.2017.07.003_bib17","unstructured":"Prineas, R. J., Crow, R. S., & Blackburn, H. The Minnesota Code Manual of Electrocardiographic Findings. John Wright PSC: Littleton, MA, USA, 1982."},{"key":"10.1016\/j.jnma.2017.07.003_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1538-7836.2010.04085.x","article-title":"A\u00a0comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice","volume":"9","author":"Van Staa","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jnma.2017.07.003_bib19","article-title":"A\u00a0new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score","volume":"2","author":"Singer","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jnma.2017.07.003_bib20","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.jacc.2014.09.051","article-title":"Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study","volume":"64","author":"Bonde","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jnma.2017.07.003_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.HYP.35.1.13","article-title":"Effect of obesity on electrocardiographic left venticular hypertrophy in hypertensive patients: the losartan intervention for endpoint (LIFE) reduction in hypertension study","volume":"35","author":"Okin","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.jnma.2017.07.003_bib22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0895-7061(98)00024-7","article-title":"Time course of complete normalization of left ventricular hypertrophy during long-term antihypertensive therapy with angiotensin converting enzyme inhibitors","volume":"11","author":"Franz","year":"1998","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jnma.2017.07.003_bib23","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(09)60443-8","article-title":"Development of a risk score for atrial fibrillation (Framingham heart study): a community-based cohort study","volume":"373","author":"Schnabel","year":"2009","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.jnma.2017.07.003_bib24","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/archinternmed.2010.434","article-title":"Validation of an atrial fibrillation risk algorithm in whites and African Americans","volume":"170","author":"Schnabel","year":"2010","journal-title":"Arch Intern Med"},{"issue":"22","key":"10.1016\/j.jnma.2017.07.003_bib25","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/CIRCULATIONAHA.107.762229","article-title":"Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial","volume":"118","author":"Davis","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jnma.2017.07.003_bib26","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1161\/CIRCULATIONAHA.110.012575","article-title":"Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"124","author":"Piller","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jnma.2017.07.003_bib27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/HYPERTENSIONAHA.115.05728","article-title":"Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients","volume":"66","author":"Okin","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.jnma.2017.07.003_bib28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jacc.2004.06.080","article-title":"Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation. The losartan intervention for end point reduction in hypertension (LIFE) study","volume":"45","author":"Wachtell","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jnma.2017.07.003_bib29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/archinternmed.2010.427","article-title":"Antihypertensive treatment and development of heart failure in hypertension: a bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk","volume":"171","author":"Sciarretta","year":"2011","journal-title":"Arch Intern Med"}],"container-title":["Journal of the National Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002796841730161X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002796841730161X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:16:43Z","timestamp":1758435403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002796841730161X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S002796841730161X"],"URL":"https:\/\/doi.org\/10.1016\/j.jnma.2017.07.003","relation":{},"ISSN":["0027-9684"],"issn-type":[{"type":"print","value":"0027-9684"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors Influencing Outcomes of Atrial Fibrillation in ALLHAT","name":"articletitle","label":"Article Title"},{"value":"Journal of the National Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnma.2017.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the National Medical Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}